Orchid Pharma Ltd.

•

orchidpharma.comBSE: 524372NSE: ORCHPHARMA

Market Cap₹ 5,717 Cr.

Current Price

High / Low₹ 1,133 / 480

Stock P/E146.8

Book Value₹ 232

Price to Book2.98

Dividend Yield0.00 %

ROCE8.5 %

ROE8.4 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2022 • Cephalosporin API - Manufactured Goods: 98.8% • Other Operating Revenues: 0.6% • Non Penicillin Non Cephalosporin FDF - Manufactured Goods: 0.3%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company comfortably covers its interest (8.1x coverage)
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 40.9% versus prior year
A large part of profit comes from other income (42.5% of PBT)
Company has a low return on capital employed of 8.8%
Company has a low return on equity of 8.6% over last 3 years
Receivables are growing faster than sales - a possible quality concern

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ORCHPHARMA	954.70	659.73	5717.24	0.00	3.22	-78.38	304.17	75.89	8.05	4.82

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	183	199	221	217	244	223	217	237	173	194	207	238	304
	161	175	185	188	211	193	191	203	159	194	204	209	302
Operating Profit	22	24	36	29	33	30	26	34	14	-1	3	29	2
OPM %	12.10%	11.92%	16.28%	13.32%	13.60%	13.29%	12.13%	14.46%	8.20%	-0.35%	1.37%	12.20%	0.62%
	2	8	7	13	8	8	10	6	16	15	3	14	10
Interest	6	4	4	3	3	3	4	4	3	4	3	3	2
Depreciation	8	8	9	8	8	9	9	9	9	9	9	9	11
Profit before Tax	11	20	31	30	29	26	24	28	18	2	-6	31	12
Tax %	0.00%	0.00%	0.00%	-10.78%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.00%	0.00%	0.00%
Net Profit	11	20	31	33	29	26	24	28	18	2	-6	31	12
	2.64	4.40	6.42	6.86	5.74	5.05	4.71	5.49	3.59	0.44	-1.15	6.03	1.99

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	879	755	644	584	481	451	557	666	819	922	943
	705	663	622	590	470	392	498	582	709	811	910
Operating Profit	174	92	22	-6	11	59	59	84	111	111	33
OPM %	19.79%	12.19%	3.45%	-1.08%	2.37%	13.04%	10.54%	12.66%	13.52%	12.00%	3.51%
	-28	-153	20	42	24	6	9	59	31	45	43
Interest	294	331	310	7	6	52	33	33	17	15	12
Depreciation	143	139	133	130	118	109	87	55	33	34	38
Profit before Tax	-292	-532	-401	-101	-88	-96	-53	55	92	106	39
Tax %	5.92%	9.04%	11.51%	-0.00%	-0.00%	-0.00%	-0.00%	0.00%	-3.53%	0.00%	0.00%
Net Profit	-274	-484	-355	-101	-88	-96	-53	55	95	106	39
EPS	-31.51	-54.36	-39.93	-11.36	-16.87	-28.70	-1.18	13.28	18.68	20.99	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: -6%
5 Years:: 14%
3 Years:: 18%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: 19%
3 Years:: 19%
1 Year:: 32%

RETURN ON EQUITY

10 Years:: -50%
5 Years:: 1%
3 Years:: 9%
Last Year:: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	89	89	89	89	41	41	41	41	51	51
	82	-353	-763	-844	757	641	637	691	1,168	1,273
	3,264	3,203	3,533	3,404	566	453	268	331	135	174
Trade Payables	353	404	327	270	60	69	121	129	179	170
	174	118	25	75	26	22	28	31	20	28
Total Liabilities	3,963	3,461	3,211	2,993	1,450	1,224	1,094	1,223	1,552	1,697
	1,540	1,402	1,291	1,161	858	670	584	573	616	613
Capital Work in Progress	265	274	257	264	15	7	10	46	10	28
	125	125	125	0	0	15	49	50	69	69
	210	197	185	167	141	151	173	229	264	326
	0	0	0	0	0	0	0	0	189	242
Cash & Bank	313	256	301	324	172	19	4	22	257	164
	1,509	1,207	1,052	1,076	264	362	275	303	145	254
Total Assets	3,963	3,461	3,211	2,993	1,450	1,224	1,094	1,223	1,552	1,697

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	211	318	13	19	70	19	91	14	131	27
Cash from Investing	-1	-9	-28	45	167	67	113	-27	-316	-37
Cash from Financing	-287	-366	33	-0	-250	-165	-217	31	167	25
	-76	-57	11	60	-3	-73	-14	18	-18	16

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-30.83	-54.36	-39.93	-11.36	-21.67	-23.49	-12.93	13.54	18.68	20.99
Book Value (₹)	19.24	-29.66	-75.78	-84.86	195.47	166.93	166.10	179.33	240.21	261.06
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	-14.71	-38.69	-24.95	3.25	7.22	3.19	8.39	26.96	25.23	27.78
PROFITABILITY
Operating Margin %	22.32%	14.56%	6.48%	1.82%	7.41%	14.47%	12.16%	15.58%	13.52%	12.00%
Net Margin %	-30.82%	-63.11%	-54.74%	-17.31%	-18.38%	-21.27%	-9.47%	8.30%	11.56%	11.55%
ROE %	-89.85%	0.00%	0.00%	0.00%	-413.02%	-12.96%	-7.76%	7.84%	9.72%	8.38%
ROCE %	0.08%	-6.44%	-3.40%	-3.77%	-4.28%	-3.50%	-1.86%	8.77%	8.96%	8.52%
	-6.76%	-13.03%	-10.65%	-3.26%	-3.98%	-7.17%	-4.55%	4.77%	6.83%	6.56%
EFFICIENCY
Debtor Days	137	148	110	89	79	80	96	102	89	85
Inventory Days	93	97	108	110	117	118	106	110	110	117
Payable Days	282	376	403	392	301	103	110	119	116	117
	-53	-131	-185	-192	-105	96	92	93	83	85
FINANCIAL HEALTH
Debt to Equity (x)	18.78x	-11.77x	-4.75x	-4.28x	0.71x	0.66x	0.40x	0.45x	0.11x	0.13x
Interest Coverage (x)	0.01x	-0.61x	-0.29x	-14.12x	-13.21x	-0.84x	-0.58x	2.68x	6.48x	8.13x
	1.01x	0.63x	0.35x	0.34x	4.24x	4.18x	1.91x	1.51x	3.73x	3.31x
GROWTH
Revenue Growth %	-49.35%	-14.10%	-14.72%	-9.40%	-17.55%	-6.34%	23.58%	19.56%	23.05%	12.52%
Operating Profit Growth %	-45.16%	-43.84%	-62.28%	-74.76%	235.85%	82.86%	3.79%	53.20%	36.37%	10.18%
Net Profit Growth %	-43.57%	-76.33%	26.54%	71.56%	12.46%	-8.38%	44.96%	204.69%	71.50%	12.38%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	38.02%	12.38%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	55.95x	37.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	4.35x	2.98x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	36.61x	25.35x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84	69.84
	1.42	1.94	2.53	2.69	1.39	1.56	1.17	0.87	0.80
	18.93	18.30	19.00	20.10	19.43	19.04	19.39	20.24	20.75
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public	9.81	9.93	8.64	7.38	9.34	9.57	9.60	9.05	8.61

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Change in Management

2026-09-03 - Orchid Pharma Limited has informed the Exchange about appointment of cost auditor and change in designation of a Director.

2026-09-03

Outcome of Board Meeting

2026-09-03 - Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-08-24

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-24 - Orchid Pharma Limited has informed the Exchange about Transcript

2026-08-21

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-21 - Orchid Pharma Limited has informed the Exchange about Link of Recording

2026-08-20

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-20 - Orchid Pharma Limited has informed the Exchange about Presentation

2026-08-17

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Orchid Pharma Limited has informed the Exchange about Schedule of meet

2026-08-14

Monitoring Agency Report

2026-08-14 - Monitoring Agency Report for the Ouarter-I of Financial Year 2026-27, ended on June 30, 2026- Orchid Pharma Limited ("the Company")

2026-08-14

Outcome of Board Meeting

2026-08-14 - Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

2026-08-14

Outcome of Board Meeting

2026-08-14 - Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

News

Recent coverage and analyst commentary for ORCHPHARMA

Loading news…

🤖

AI Stock Analyst

Orchid Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ORCHPHARMA

954.70

659.73

5717.24

0.00

3.22

-78.38

304.17

75.89

8.05

4.82

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

183

199

221

217

244

223

217

237

173

194

207

238

304

161

175

185

188

211

193

191

203

159

194

204

209

302

Operating Profit

-1

OPM %

12.10%

11.92%

16.28%

13.32%

13.60%

13.29%

12.13%

14.46%

8.20%

-0.35%

1.37%

12.20%

0.62%

Interest

Depreciation

Profit before Tax

-6

Tax %

0.00%

-10.78%

0.00%

-0.00%

0.00%

Net Profit

-6

2.64

4.40

6.42

6.86

5.74

5.05

4.71

5.49

3.59

0.44

-1.15

6.03

1.99

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

879

755

644

584

481

451

557

666

819

922

943

705

663

622

590

470

392

498

582

709

811

910

Operating Profit

174

-6

111

OPM %

19.79%

12.19%

3.45%

-1.08%

2.37%

13.04%

10.54%

12.66%

13.52%

12.00%

3.51%

-28

-153

Interest

294

331

310

Depreciation

143

139

133

130

118

109

Profit before Tax

-292

-532

-401

-101

-88

-96

-53

106

Tax %

5.92%

9.04%

11.51%

-0.00%

0.00%

-3.53%

0.00%

Net Profit

-274

-484

-355

-101

-88

-96

-53

106

EPS

-31.51

-54.36

-39.93

-11.36

-16.87

-28.70

-1.18

13.28

18.68

20.99

—

Dividend Payout %

0.00%

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Equity Capital

-353

-763

-844

757

641

637

691

1,168

1,273

3,264

3,203

3,533

3,404

566

453

268

331

135

174

Trade Payables

353

404

327

270

121

129

179

170

174

118

Total Liabilities

3,963

3,461

3,211

2,993

1,450

1,224

1,094

1,223

1,552

1,697

1,540

1,402

1,291

1,161

858

670

584

573

616

613

Capital Work in Progress

265

274

257

264

125

210

197

185

167

141

151

173

229

264

326

189

242

Cash & Bank

313

256

301

324

172

257

164

1,509

1,207

1,052

1,076

264

362

275

303

145

254

Total Assets

3,963

3,461

3,211

2,993

1,450

1,224

1,094

1,223

1,552

1,697

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

211

318

131

Cash from Investing

-1

-9

-28

167

113

-27

-316

-37

Cash from Financing

-287

-366

-0

-250

-165

-217

167

-76

-57

-3

-73

-14

-18

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

-30.83

-54.36

-39.93

-11.36

-21.67

-23.49

-12.93

13.54

18.68

20.99

Book Value (₹)

19.24

-29.66

-75.78

-84.86

195.47

166.93

166.10

179.33

240.21

261.06

Dividend per Share (₹)

0.00

Cash EPS (₹)

-14.71

-38.69

-24.95

3.25

7.22

3.19

8.39

26.96

25.23

27.78

PROFITABILITY

Operating Margin %

22.32%

14.56%

6.48%

1.82%

7.41%

14.47%

12.16%

15.58%

13.52%

12.00%

Net Margin %

-30.82%

-63.11%

-54.74%

-17.31%

-18.38%

-21.27%

-9.47%

8.30%

11.56%

11.55%

ROE %

-89.85%

0.00%

-413.02%

-12.96%

-7.76%

7.84%

9.72%

8.38%

ROCE %

0.08%

-6.44%

-3.40%

-3.77%

-4.28%

-3.50%

-1.86%

8.77%

8.96%

8.52%

-6.76%

-13.03%

-10.65%

-3.26%

-3.98%

-7.17%

-4.55%

4.77%

6.83%

6.56%

EFFICIENCY

Debtor Days

137

148

110

102

Inventory Days

108

110

117

118

106

110

117

Payable Days

282

376

403

392

301

103

110

119

116

117

-53

-131

-185

-192

-105

FINANCIAL HEALTH

Debt to Equity (x)

18.78x

-11.77x

-4.75x

-4.28x

0.71x

0.66x

0.40x

0.45x

0.11x

0.13x

Interest Coverage (x)

0.01x

-0.61x

-0.29x

-14.12x

-13.21x

-0.84x

-0.58x

2.68x

6.48x

8.13x

1.01x

0.63x

0.35x

0.34x

4.24x

4.18x

1.91x

1.51x

3.73x

3.31x

GROWTH

Revenue Growth %

-49.35%

-14.10%

-14.72%

-9.40%

-17.55%

-6.34%

23.58%

19.56%

23.05%

12.52%

Operating Profit Growth %

-45.16%

-43.84%

-62.28%

-74.76%

235.85%

82.86%

3.79%

53.20%

36.37%

10.18%

Net Profit Growth %

-43.57%

-76.33%

26.54%

71.56%

12.46%

-8.38%

44.96%

204.69%

71.50%

12.38%

0.00%

38.02%

12.38%

VALUATION

P/E (x)

0.00x

55.95x

37.00x

P/B (x)

0.00x

4.35x

2.98x

Dividend Yield %

0.00%

0.00x

36.61x

25.35x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.84

1.42

1.94

2.53

2.69

1.39

1.56

1.17

0.87

0.80

18.93

18.30

19.00

20.10

19.43

19.04

19.39

20.24

20.75

Government

0.00

Public

9.81

9.93

8.64

7.38

9.34

9.57

9.60

9.05

8.61

Orchid Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Orchid Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI